In vitro eye irritation testing using the open source reconstructed hemicornea - a ring trial.
Karsten R Mewes1, Maria Engelke2, Michaela Zorn-Kruppa3
1Henkel AG & Co. KGaA; Düsseldorf, Germany.
ALTEX
|January 15, 2017
Summary
Two novel in vitro methods for classifying eye irritating chemicals using 3D hemicornea models showed promise. The second method achieved 100% between-laboratory reproducibility, effectively identifying severe irritants.
Area of Science:
- Toxicology
- Ophthalmology
- In vitro testing
Background:
- Reliable in vitro methods are needed for classifying eye irritating chemicals.
- Existing methods require validation across multiple laboratories.
- Open source 3D reconstructed hemicornea models offer a promising alternative.
Purpose of the Study:
- To assess the inter-laboratory transferability and reproducibility of two new in vitro methods for eye irritant classification.
- To evaluate the performance of these methods using 3D reconstructed hemicornea models.
- To determine the suitability of these methods for regulatory use.
Main Methods:
- A ring trial involving three independent laboratories was conducted.
- Two distinct in vitro methods utilizing open source 3D hemicornea models were tested.
- Method 1: Histological analysis of injury depth. Method 2: Tissue viability assessment of epithelium and stroma.
Main Results:
- The second method demonstrated 100% between-laboratory reproducibility, while the first achieved 62.5%.
- Both methods successfully discriminated Category 1 (severe) eye irritants from non-irritants.
- Optimization is needed to improve selectivity between No Category and Category 2 irritants.
Conclusions:
- The second in vitro method shows high reliability and potential for classifying eye irritating chemicals.
- Both methods can be utilized in a top-down approach for hazard identification.
- Further refinement is necessary for precise classification of milder irritants.
Keywords:
Open source 3D hemicornea equivalentin vitro eye irritation testingtest performancedepth of injuryring trial

